Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45+
SponsorVold Vision P.L.L.C
About this trial
This study is designed to determine how well patients with glaucoma can see following cataract surgery with a special type of lens called an extended-depth-of-focus (EDOF) lens. This lens is intended to reduced the patients need for glasses following cataract surgery. Patients will also undergo a minimally invasive type of glaucoma surgery using a special type of stent to reduce eye pressure, with the goal of better glaucoma control and the reduction in the need for medications to control eye pressure.
Eligibility criteria
Qualifiers
Male or female subjects 45 years of age or older
A visually significant age-related cataract in both eyes
Diagnosis of mild OAG
VF characteristics consistent with glaucoma with mean deviation not worse than -6.00 dB and without fixation threatening scotoma AND/OR with nerve abnormalities consistent with glaucoma (rim notching, rim thinning, disc hemorrhage, nerve fiber layer loss)
Disqualifiers
Previous incisional glaucoma surgery or cilio-ablative surgery
Prior laser trabeculoplasty within 90 days of surgery
Pseudoexfoliative, angle closure, uveitic, congenital, traumatic, angle recession, or neovascular glaucoma.
Moderate glaucoma with VF mean deviation between -6.00 dB and -12.00 dB
Trial design
Treatments tested in this trial
- Vivity IOL
Treatment groups
25 Participants
are divided into 1 treatment groupSponsors and collaborators
Vold Vision P.L.L.C
Lead sponsor
Alcon Research
Collaborator
Source ClinicalTrials.gov